T2 Biosystems Inc expected to post a loss of $1.70 a share - Earnings Preview

T2 Biosystems

10/03/2023 23:21

* T2 Biosystems Inc  TTOO.OQ   TTOO.O  is expected to show a
fall
in quarterly revenue when it reports  results on March 13. 
    * The Lexington Massachusetts-based  company is expected to
report
 a 22.6% decrease in revenue to $5.4 million from $6.98 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for T2 Biosystems Inc
is for
a loss of $1.70 per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for T2
Biosystems Inc
is $1.5​, above​ its last closing price of $0.56. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -2.05       -2.04      -2.95     Missed  -44.4
 Jun. 30 2022  -4.50       -4.50      -5.00     Missed  -11.1
 Mar. 31 2022  -3.72       -3.75      -5.00     Missed  -33.3​
 Dec. 31 2021  -4.50       -4.50      -3.50     Beat    22.2
 ​​Sep.        -4.23       -4.25      -4.00     Beat    5.9
 30 2021                                                
 Jun. 30 2021  -4.00       -4.00      -4.00     Met     0​
 Mar. 31 2021  -3.83       -3.70      -3.50     Beat    5.4
 Dec. 31 2020  -3.36       -3.40      -3.50     Missed  -2.9
 This summary was machine generated March 10 at 23:21 GMT.  All
figures in US dollars  unless otherwise stated